Factors influencing the implementation of shared decision-making in breast cancer care: protocol for a mixed-methods study
Standard
Factors influencing the implementation of shared decision-making in breast cancer care: protocol for a mixed-methods study. / Bravo, Paulina; Dois, Angelina; Villarroel, Luis; González-Agüero, Marcela; Fernández-González, Loreto; Sánchez, César; Martinez, Alejandra; Turén, Valentina; Quezada, Constanza; Guasalaga, María Elisabeth; Härter, Martin.
In: BMJ OPEN, Vol. 13, No. 7, 20.07.2023, p. e074111.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Factors influencing the implementation of shared decision-making in breast cancer care: protocol for a mixed-methods study
AU - Bravo, Paulina
AU - Dois, Angelina
AU - Villarroel, Luis
AU - González-Agüero, Marcela
AU - Fernández-González, Loreto
AU - Sánchez, César
AU - Martinez, Alejandra
AU - Turén, Valentina
AU - Quezada, Constanza
AU - Guasalaga, María Elisabeth
AU - Härter, Martin
N1 - © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2023/7/20
Y1 - 2023/7/20
N2 - INTRODUCTION: Chile is committed to actively involving patients in their healthcare. However, little is known about how this is translated into clinical encounters. Breast cancer (BC) is the first cause of cancer-related death in Chilean women. National policy guarantees standard care, and treatment decisions should be made along this process that can have long-term consequences for women. So, BC is a particularly well-suited case study to understand the complexity of patient participation in decision-making.OBJECTIVE: To identify the factors that affect the active involvement of patients in the BC treatment decision-making process, considering the perspectives and practices of health professionals and women facing the disease.METHOD AND ANALYSIS: We will conduct a mixed-method study through a convergent parallel design in three stages: (1) A qualitative study: non-participant observation of the tumour board (TB) meetings; semi-structured interviews with key informants from TBs; documentary analyses; semi-structured interviews with women facing BC; and non-participant observations of clinical encounters; (2) a cross-sectional study with 445 women facing BC stages I-III from three hospitals in Santiago, Chile. We will measure the level of expected participation, experienced participation, decisional conflict, quality of life (QoL) and satisfaction with healthcare. Descriptive analysis will be performed, and multivariable binary logistic regression models will be adjusted to identify factors associated with high levels of QoL or satisfaction; (3) an integration study will bring together the data through a joint display technique.ETHICS AND DISSEMINATION: The study has been conceived and will be conducted according to international and local agreements for ethical research. Ethical approval has been granted by two Ethics Committees in Chile.The results will be disseminated to scientific and lay audiences (publications in scientific journals and conferences, seminars and a website for plain language dissemination).
AB - INTRODUCTION: Chile is committed to actively involving patients in their healthcare. However, little is known about how this is translated into clinical encounters. Breast cancer (BC) is the first cause of cancer-related death in Chilean women. National policy guarantees standard care, and treatment decisions should be made along this process that can have long-term consequences for women. So, BC is a particularly well-suited case study to understand the complexity of patient participation in decision-making.OBJECTIVE: To identify the factors that affect the active involvement of patients in the BC treatment decision-making process, considering the perspectives and practices of health professionals and women facing the disease.METHOD AND ANALYSIS: We will conduct a mixed-method study through a convergent parallel design in three stages: (1) A qualitative study: non-participant observation of the tumour board (TB) meetings; semi-structured interviews with key informants from TBs; documentary analyses; semi-structured interviews with women facing BC; and non-participant observations of clinical encounters; (2) a cross-sectional study with 445 women facing BC stages I-III from three hospitals in Santiago, Chile. We will measure the level of expected participation, experienced participation, decisional conflict, quality of life (QoL) and satisfaction with healthcare. Descriptive analysis will be performed, and multivariable binary logistic regression models will be adjusted to identify factors associated with high levels of QoL or satisfaction; (3) an integration study will bring together the data through a joint display technique.ETHICS AND DISSEMINATION: The study has been conceived and will be conducted according to international and local agreements for ethical research. Ethical approval has been granted by two Ethics Committees in Chile.The results will be disseminated to scientific and lay audiences (publications in scientific journals and conferences, seminars and a website for plain language dissemination).
KW - Humans
KW - Female
KW - Breast Neoplasms/therapy
KW - Decision Making
KW - Quality of Life
KW - Cross-Sectional Studies
KW - Research Design
U2 - 10.1136/bmjopen-2023-074111
DO - 10.1136/bmjopen-2023-074111
M3 - SCORING: Journal article
C2 - 37474182
VL - 13
SP - e074111
JO - BMJ OPEN
JF - BMJ OPEN
SN - 2044-6055
IS - 7
ER -